Presentation TCT 2019 Potential Study Designs to Address the Mortality Safety Signal Presenter: Laura Mauri September 26, 2019 REGISTER for free or LOG IN to view this content Endovascular Presentation TCT 2019 Up Next Presentation TCT 2019 New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated) Presenter: Konstantinos Katsanos September 26, 2019 More slides + Presentation TCT 2019 Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible? Presenter: Elazer Edelman September 26, 2019 Presentation TCT 2019 Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data Presenter: Krishna Rocha-Singh September 26, 2019 We Recommend
Presentation TCT 2019 New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated) Presenter: Konstantinos Katsanos September 26, 2019
Presentation TCT 2019 Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible? Presenter: Elazer Edelman September 26, 2019
Presentation TCT 2019 Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data Presenter: Krishna Rocha-Singh September 26, 2019